2020, Number 3
<< Back Next >>
Rev Cub de Reu 2020; 22 (3)
Osteonecrosis of the femoral head and HIV/AIDS infection in the Cuban epidemic
Reyes LGA, Mazón DC, Gil RG, García MM, Torres FA, Millán MJC, Carrillo LD, Guibert TM
Language: Spanish
References: 40
Page:
PDF size: 514.87 Kb.
ABSTRACT
Introduction:
Avascular Necrosis or Osteonecrosis (ON) is a process associated with the blood supply deficit with ischemia in the nutritional vessels of the interested bones determining chronic pain, functional disability. In recent years with the growing development of the HIV epidemic, a marked increase in this condition has been observed.
Objective:
To determine an characterize in the clinical and epidemiological order the Cuban HIV + patients, who developed ON in the context of the HIV epidemic in a series of 285 HIV + cases with highly effective ARV therapy including tenofovir.
Methods:
Prospective analytical pilot study in a series of 285 patients, with HIV-AIDS infection adults treated in the IPK of Cuba in the later era (years 2003-17) to high-efficiency ARV therapy (TARVAE). Patients diagnosed with HIV / AIDS who offered their informed consent to participate in the study were included, and the research was approved by the IPK Ethics Committee.
Results:
Average age 41 (15-71) years (p <0.05). Survival 12 years by studies of Kaplan and Maier. Marked male predominance with 230 (81%), 55 (19.2%) women, white skin color, and 50-59 age group with 146 (51.2%) (p <0.05); data similar to the rest of the Cuban population according to other COPCORD Epidemiological studies. (18) Sexual and HIVH prevalent HIV acquisition mode with 192 (67.3%). 154 (54%) had an undetectable viral load. We found 3 (1.05%) patients who developed ON, with an average age of 52 (40-61a), 2 patients in right hip, and one bilateral avascular necrosis of the hips, all with radiological changes of this condition. As associated FR, one patient had hyperlipidemia, another 2 smoker, and 1 alcohol, all 3 with CD4 + T cell count <200 And high viral load. All cases had TARVAE with protease inhibitors, and reverse transcriptase, including Tenofovir.
Conclusions:
Our report is aimed at showing a low frequency of ON in our series of 285 patients studied in the Cuban HIV epidemic. The hips were the sites of ON, with 1 patients bilateral involvement. Hyperlipidemia, tabaquism and alcohol were the principal risk factors presented and low level of CD4 + T cels, and high viral load. We were unable to establish causal relationships between the recognized risk factors reported in the literature, HAART and the appearance of ON, all of which leave the role played by HIV infection per se in the development of this complication, or the effects of other variables that we have not explored in this preliminary study.
REFERENCES
Larson E, Jones LC, Goodman SB, Koo KH, Cui Q. Early-stage osteonecrosis of the femoral head: where are we and where are we going in year 2018? Int Orthop. Jul 2018;42(7):1723-1728. Available from: doi: 10.1007/s00264-018-3917-8. Epub 2018.
2 . Capó Soliveres. Necrosis avascular en afecciones reumáticas. Revista Española de Cirugía Osteoarticular. Jul-Sep 2016;267(51):135.
Renovell P, Silvestre A, Escribá I. Etiología de la necrosis de cabeza femoral. Rev Esp Cir Osteoart. 2009;238:58-64.
George CB, Vasileios S, Javad P, Panayiotis S. Osteonecrosis of the femoral head. Orthopedics. 2011;1:39-48.
5 . Mc Curdie FK, Roi D, Sahu A, Singh Sandhu G. Severe bilateral knee osteonecrosis in a young man with human immunodeficiency virus. Radiol Case Rep. 9 Nov 2018;14(2):208-212. Available from: doi: 10.1016/j.radcr.2018.10.032. eCollection 2019 Feb.
Miller KD, Masur H, Jones EC, et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med. 2002;13(7):17-25.
Anagnostakos K. Coagulation Abnormalities in Osteonecrosis and Bone Marrow Edema Syndrome. Orthopedics. 2013;36:290-300.
Miao Q, Hao S, Li H, Sun F, Wang X. Expression of osteoprotegerin, RANK and RANKL genes in femoral head avascular necrosis and related signaling pathway. Int J Clin Exp Pathol. 2015 Sep 1;8(9):10460-7.
9 . Yao Q, Frank M, Glynn M, Altman RD. Rheumatic manifestations in HIV-1 infected in-patients and literature review. Clin Exp Rheumatol. Sep-Oct 2008;26(5):799-806.
Gutiérrez F, Padilla S, Masia M, Flores J, Boix V, Merino E. Osteonecrosis in patients infected with HIV: clinical epidemiology and natural history in a large case series from Spain. J Adquir Inmune Defic Syndr. 2006;42(3):286-92.
Woo S, Hellstein J, Kalmar J. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006;144(10):753-61.
Lawson E, Walker-Bone K. The changing spectrum of rheumatic disease in HIV infection. Br Med Bull. 2012 Sep 2;103(1):203-21. Available from: doi: 10.1093/bmb/lds022. Epub 2012 Aug 8.
Allison G, Bostrom M, Glesby M. Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management. AIDS. 2003;17(1):1-9.
Ries M, Barcohana B, Davidson A, Jergesen H, Paiement G. Association between human immunodeficiency virus and osteonecrosis of the femoral head. J Arthroplasty. 2002;17(2):135-9.
Rueda JC, Duque MAQ, Mantilla RD, Iglesias-Gamarra A. Osteonecrosis and antiphospholipid syndrome. J Clin Rheumatol. 2009;15:130-2.
Molia A, Strady C, Rouger C, Beguinot I, Berger J, Trenque T. Osteonecrosis in six HIV-infected patients receiving highly active antiretroviral therapy. Ann Pharmacother. 2004;38(12):2050-4.
17 . Reyes Llerena GA, Guibert Toledano M, Navarro Camero A, García Garcés M, Sanchoyerto López R, Pérez Ávila J. Lupus eritematoso sistémico en la epidemia VIH/SIDA en Cuba. Rev Cubana Reumatol. 2019;21(1):Supp 1.
Reyes Llerena GA, Guibert Toledano M, Penedo Coello A, et al. Community study based to estimate the prevalence and burden of illness of rheumatic diseases in Cuba. A COPCORD Study. J Clin Rheumatol. 2009;15:51-5.
Borges AH, Hoy J, Florence E, Sedlacek D, Jurgen Stellbrink H, Uzdaviniene V, et al. Fracture and osteonecrosis in a large international VIH Cohort. Clinical Infectious Diseases EuroSida. 2017;64(10):1413-21.
Hansen AB, Gerstoft J, Kronborg G, et al. Incidence of low and high-energy fractures in persons with and without HIV infection: A Danish population-based cohort study. AIDS. 2012;26:285-93.
Güerri-Fernandez R, Vestergaard P, Carbonell C, et al. HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: A population-based cohort study. J Bone Miner Res. 2013;28:1259-63.
Arbab D, König DP. Atraumatic femoral head necrosis in adults: Epidemiology, etiology, diagnosis and treatment. Dtsch Arztebl Int. 2016 Jan;113(3):31-8. Available from: doi: 10.3238/arztebl.2016.0031
Morse CG, Mican JM, Jones EC, et al. The incidence and natural history of osteonecrosis in HIV-infected adults. Clin Infect Dis. 2007;44:739-48.
Moreno-Cuerda VJ, Morales M, Tamargo L, Rubio R, Pulido F. Avascular necrosis of the bone in patients with HIV infection: an emergent problem. Rev Clin Esp. 2006 Sep;206(8):392-6.
Weinstein RS. Glucocorticoid-induced osteonecrosis. Endocrine. 2012;41:183-90.
Michalecki L, Gabrys D, Kulik R, Wydmanski J, Trela K. Radiotherapy induced hip joint avascular necrosis-Two cases report. Reports Pract Oncol Radiother. 2011;16:198-201.
Gao Y-S, Zhang CQ. Cytotherapy of osteonecrosis of the femoral head: a mini review. Int Orthop. 2010;34:779-82.
28 . Belmahi N, Boujraf S, Larwanou MM, El Ouahabi H. Avascular necrosis of the femoral head: An exceptional complication of cushing's disease. Ann Afr Med. Oct-Dec 2018;17(4):225-227. Available from: doi: 10.4103/aam.aam_75_17.
Adler RA, El-Hajj FG, Bauer DC. Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for bone and mineral research. J Bone Miner Res. 2016;31(1):16.
Morse C, Mican J, Jones E, Joe G, Rick M, Formentini E. The incidence and natural history of osteonecrosis in HIV-infected adults. Clin Infect Dis. 2007;44(5):739-48.
Shah KN, Racine J, Jones LC. Pathophysiology and risk factors for osteonecrosis. Curr Rev Musculoskelet Med. 2015;8:201-209.
Parsons SJ, Steele N. Osteonecrosis of the femoral head: Part 2- Options for treatment. Curr Orthop. Elsevier Ltd. 2008;22:349-58.
Jones KB, Seshadri T, Krantz R, Keating A, Ferguson PC. Cell-Based therapies for osteonecrosis of the femoral head. Biol Blood Marrow Transplant. 2008;14:1081-7.
Fessel J. There are many potential medical therapies for atraumatic osteonecrosis. Rheumatol. 2013;52:235-41.
Agarwala S, Banavali SD, Vijayvargiya M. Bisphosphonate combination therapy in the management of post chemotherapy avascular necrosis of the femoral head in adolescents and young adults: A retrospective study from India. J Glob Oncol. 2018;4:JGO.17.00083. available from: doi: 10.1200/JGO.17.00083
Bosco G, Vezzani G, Mrakic Sposta S, Rizzato A, Enten G, Abou-Samra A, et al. Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress. J Enzyme Inhib Med Chem. 2018 Dec;33(1):1501-5. Available from: doi: 10.1080/14756366.2018.1485149.
Vezzani G, Quartesan S, Cancellara P, Camporesi E, Mangar D, Bernasek T, et al. Hyperbaric oxygen therapy modulates serum OPG/RANKL in femoral head necrosis patients. J Enzyme Inhib Med Chem. 2017 Dec;32(1):707-11. Available from: doi: 10.1080/14756366.2017.1302440.
Houdek MT, Wyles CC, Collins MS, Howe BM, Terzic A, Behfar A, et al. Stem cells combined with platelet-rich plasma effectively treat corticosteroid-induced osteonecrosis of the hip: A Prospective. Clin Orthop Relat Res. 2018 Feb;476(2):388-97. Available from: doi: 10.1007/s11999.0000000000000033.
Meyer D, Behrens G, Schmidt RE, Stoll M. Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors. AIDS. 1999;13:1147-8.
Walker-Bone K, Doherty E, Sanyal K, Churchill D. Assessment and management of musculoskeletal disorders among patients living with HIV Rheumatology (Oxford). 2017 Oct;56(10):1648-61.